Visiongain has launched a new food & beverage report: Human Milk Oligosaccharides Market Report Forecasts by Product Type (2’FL, 3’FL, 3’SL, 6’SL) by Application (Functional Food & Beverage, Infant Formula, Food Supplements, and others) PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis

Human milk oligosaccharides (HMO) are major constituents of human milk and consists of various structures that are neutral or acidic and some forms are sialylated or fucosylated, which contributes to their biological functions. HMO aims to protect the infant from pathogenic infections, enable the formation of the gut microbiota, support intestinal development, and arouse immune maturation. Some types of HMO are now commercially available and are being added to infant formula alone or in combination with other prebiotics.

An increasing number of middle-class populations and rise in the number of working women are driving the growth of the instant formula business. Established companies and resultant competition in this sector are likely to ease the use of HMO in infant formula over the forecast period 2019-2029, thus driving the growth in the global HMO market. Further, demand for dietary supplements due to increased health consciousness is also anticipated to boost the market growth over the forecast period.

Companies in the market are focusing on making a strategic partnership with the established players in order to enhance the development in the global HMO market. For instance, BASF and Glycosyn announced a partnership agreement for the development and commercialization of human milk oligosaccharides (HMOs) for use in dietary supplements, functional nutrition, and medical food. Also, DuPont Nutrition and Health and Lonza Specialty Ingredients announced Joint Agreement in Human Milk Oligosaccharides.

Some of the major companies operating in the global human milk oligosaccharides market are Inbiose NV, Elicityl S.A., Jennewein Biotechnologie GmbH, Glycom A/S, Medolac Laboratories, ZuChem Inc., Glycosyn LLC, Gnubiotics Sciences Sarl, Dupont, Biostime, and Lonza Specialty Ingredients.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.